Supramolecular CRISPR-Cas9 Carrier Enables More Efficient Genome Editing |
|
|
|
CRISPR-Cas9 is a game-changing genome editing system. The direct delivery of Cas9–sgRNA complexes, such as the Cas9 ribonucleoproteins (RNPs), into the cell nucleus, is considered the safest and most efficient way to achieve genome editing. However, the Cas9 RNP has poor cellular permeability and requires a carrier molecule to get to the cell nucleus. The carriers need to bind with Cas9 RNP, carry it into the cell, prevent its degradation by intracellular organelles called endosomes, and finally release it without causing any changes to its structure.
|
|
|
|
|
|
|
Gene Editing Framework Gets Support from Biotech Ecosystem Community |
|
|
|
The Framework for Responsible Use of Gene Editing in Agriculture was developed by the Coalition for Responsible Gene Editing in Agriculture. It is meant to increase transparency and stakeholder engagement to build trust in the products derived through gene editing and those using them and is continuously getting the support of organizations in the biotech field.
|
|
|
|
|
COVID-19 Pandemic Impacts CRISPR Technology Market |
|
|
|
The global CRISPR technology market is estimated at US$2,251.21 million in 2021 and is projected to reach US$6,453.96 million by 2027. A compound annual growth rate of 19.45% is expected from 2022 to 2027, according to the latest report on the CRISPR technology market released by ReportLinker.
|
|
|
|
|
| Research and Tools |
 |
|
|
| Policy Considerations and Approvals |
 |
|
|
| Trends and Impacts |
 |
|
|
|
|
|
| Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10. |
|
|
|
|
